Embolic potential of cardiac tumors and outcome after resection: A case-control study

Stroke

Volumn 40, Issue 1, 2009, Pages 156-162

  Elbardissi, Andrew W ^a,b   Dearani, Joseph A ^b   Daly, Richard C ^b   Mullany, Charles J ^b   Orszulak, Thomas A ^b   Puga, Francisco J ^b   Schaff, Hartzell V ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Cardiac tumor; Embolism; Stroke; TIA

Indexed keywords

ADULT; ARTICLE; CANCER SURGERY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EMBOLISM; FEMALE; HEART TUMOR; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TRANSIENT ISCHEMIC ATTACK; TUMOR LOCALIZATION; AGE DISTRIBUTION; AGED; AORTA VALVE; BRAIN EMBOLISM; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; HEART ATRIUM; HEART SURGERY; MIDDLE AGED; MITRAL VALVE REGURGITATION; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICS;

ADULT; AGE DISTRIBUTION; AGED; AORTIC VALVE; CARDIAC SURGICAL PROCEDURES; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; COHORT STUDIES; COMORBIDITY; EMBOLISM; FEMALE; HEART ATRIA; HEART NEOPLASMS; HUMANS; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 60549095935     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.525709     Document Type: Article

References (34)

1. Larrieu AJ, Jamieson WR, Tyers GF, Burr LH, Munro AI, Miyagishima RT, Gerein AN, Allen P. Primary cardiac tumors: experience with 25 cases. J Thorac Cardiovasc Surg. 1982;83:339-348.
2. Vander Salm TJ. Unusual primary tumors of the heart. Semin Thorac Cardiovasc Surg. 2000;12:89-100.
3. Wold LE, Lie JT. Cardiac myxomas: a clinicopathologic profile. Am J Pathol. 1980;101:219-240.
4. St John Sutton MG, Mercier LA, Giuliani ER, Lie JT. Atrial myxomas: a review of clinical experience in 40 patients. Mayo Clin Proc. 1980;55: 371-376.
5. Goodwin JF. The spectrum of cardiac tumors. Am J Cardiol. 1968;21: 307-314.
6. Goodwin JF. Diagnosis of left atrial myxoma. Lancet. 1963;1: 464-468.
7. Greenwood WF. Profile of atrial myxoma. Am J Cardiol. 1968;21: 367-375.
8. Gowda RM, Khan IA, Nair CK, Mehta NJ, Vasavada BC, Sacchi TJ. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J. 2003;146:404-410.
9. Ngaage DL, Mullany CJ, Daly RC, Dearani JA, Edwards WD, Tazelaar HD, McGregory CG, Orszulak TA, Puga FJ, Schaff HV, Sundt TM 3rd, Zehr KJ. Surgical treatment of cardiac papillary fibroelastoma: a single center experience with eighty-eight patients. Ann Thorac Surg. 2005;80: 1712-1718.
10. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol. 1988;41:105-114.
11. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-2446.
12. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-3167.
13. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
14. Breiman L. Bagging predictors. Machine Learning. 1996;24:123-140.
15. Blackstone EH. Breaking down barriers: helpful breakthrough statistical methods you need to understand better. J Thorac Cardiovasc Surg. 2001;122:430-439.
16. Lee VH, Connolly HM, Brown RD Jr. Central nervous system manifestations of cardiac myxoma. Arch Neurol. 2007;64:1115-1120.
17. Knepper LE, Biller J, Adams HP Jr, Bruno A. Neurologic manifestations of atrial myxoma. A 12-year experience and review. Stroke. 1988;19: 1435-1440.
18. Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore). 2001; 80:159-172.
19. Sandok BA, von Estorff I, Giuliani ER. CNS embolism due to atrial myxoma: clinical features and diagnosis. Arch Neurol. 1980;37: 485-488.
20. Silverman N. Primary cardiac tumors. Ann Surg. 1980;191:127-138.
21. Chitwood WR Jr. Cardiac neoplasms: current diagnosis, pathology, and therapy. J Card Surg. 1988;3:119-154.
22. Benjamin H. Primary fibromyxoma of the heart. Arch Pathol. 1939; 27:950.
23. Heath D. Pathology of cardiac tumors. Am J Cardiol. 1968;21: 315-327.
24. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davidson TW, Davis JL, Douglas PS, Gillam LD. ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation. 1997;95:1686 -1744.
25. ElBardissi AW, Dearani JA, Daly RC, Mullany CJ, Orszulak TA, Puga FJ, Schaff HV. Analysis of benign ventricular tumors: long-term outcome after resection. J Thorac Cardiovasc Surg. 2008;135:1061-1068.
26. Roeltgen DP, Weimer GR, Patterson LF. Delayed neurologic complications of left atrial myxoma. Neurology. 1981;31:8 -13.
27. Sandok BA, von Estorff I, Giuliani ER. Subsequent neurological events in patients with atrial myxoma. Ann Neurol. 1980;8:305-307.
28. Burke AP, Cowan D, Virmani R. Primary sarcomas of the heart. Cancer. 1992;69:387-395.
29. Poole GV Jr, Breyer RH, Holliday RH, Hudspeth AS, Johnston FR, Cordell AR, Mills SA. Tumors of the heart: surgical considerations. J Cardiovasc Surg (Torino). 1984;25:5-11.
30. Reece IJ, Cooley DA, Frazier OH, Hallman GL, Powers PL, Montero CG. Cardiac tumors. Clinical spectrum and prognosis of lesions other than classical benign myxoma in 20 patients. J Thorac Cardiovasc Surg. 1984;88:439-446.
31. Wiske PS, Gillam LD, Blyden G, Weyman AE. Intracardiac tumor regression documented by two-dimensional echocardiography. Am J Cardiol. 1986;58:186-187.
32. Leu KM, Ostruszka LJ, Shewach D, Zalupski M, Sondak V, Biermann JS, Lee JS, Couwlier C, Palazzolo K, Baker LH. Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gem-citabine followed by docetaxel in the treatment of sarcoma. J Clin Oncol. 2004;22:1706-1712.
33. Fata F, O'Reilly E, Ilson D, Pfister D, Leffel D, Kelsen DP, Schwartz GK, Casper ES. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999;86:2034-2037.
34. Bakaeen FG, Reardon MJ, Coselli JS, Miller CC, Howell JF, Lawrie GM, Espada R, Ramchandani MK, Noon GP, Weilbaecher DG, DeBakey ME. Surgical outcome in 85 patients with primary cardiac tumors. Am J Surg. 2003;186:641-647; discussion 647.